Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Co-Diagnostics Inc (CODX)

Co-Diagnostics Inc (CODX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 227,981
  • Shares Outstanding, K 24,916
  • Annual Sales, $ 40 K
  • Annual Income, $ -6,270 K
  • 60-Month Beta N/A
  • Price/Sales 1,235.96
  • Price/Cash Flow N/A
  • Price/Book 48.26

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.08
  • Number of Estimates 1
  • High Estimate -0.08
  • Low Estimate -0.08
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.01%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.57 +64.27%
on 03/10/20
21.75 -57.93%
on 02/28/20
-6.81 (-42.67%)
since 02/27/20
3-Month
0.88 +939.77%
on 01/06/20
21.75 -57.93%
on 02/28/20
+8.22 (+886.63%)
since 12/27/19
52-Week
0.69 +1,218.44%
on 06/05/19
21.75 -57.93%
on 02/28/20
+8.04 (+724.32%)
since 03/27/19

Most Recent Stories

More News
Co-Diagnostics (NASDAQ:CODX) Reiterated Buy; Joins Distinguished Group Racing to Meet Unprecedented Global Demand for COVID-19 Testing

The global shortage of COVID-19 testing kits is hitting the United States and other nations hard, but a recent FDA policy change means that Co-Diagnostics (NASDAQ:CODX) can help meet this unprecedented...

CODX : 9.15 (-2.66%)
Coronavirus Scare Supports These Biotech ETFs & Stocks

Growing coronavirus concerns provide some support to these biotech ETFs and stocks amid a massive market sell-off.

IBB : 104.71 (-1.95%)
CNCR : 19.34 (-0.97%)
BBH : 124.08 (-1.58%)
ARKG : 31.36 (-3.88%)
AYTU : 1.8200 (+13.75%)
FTSV : 94.55 (+0.08%)
VIR : 34.30 (+7.19%)
IDNA : 26.50 (-0.79%)
CODX : 9.15 (-2.66%)
CNTG : 15.98 (-6.00%)
The Zacks Analyst Blog Highlights: Danaher, Quidel, Aytu BioScience, QIAGEN and Co-Diagnostics

The Zacks Analyst Blog Highlights: Danaher, Quidel, Aytu BioScience, QIAGEN and Co-Diagnostics

QGEN : 40.45 (-0.88%)
DHR : 138.58 (-0.06%)
QDEL : 94.31 (+6.00%)
AYTU : 1.8200 (+13.75%)
CODX : 9.15 (-2.66%)
Coronavirus Test Kit Demand to Drive These 3 Stocks

Point-of-care testing enables better patient triage, bed management, and patient care decisions. Here are three stocks to benefit as demand rises.

QGEN : 40.45 (-0.88%)
DHR : 138.58 (-0.06%)
QDEL : 94.31 (+6.00%)
AYTU : 1.8200 (+13.75%)
CODX : 9.15 (-2.66%)
PreCheck Begins Filling Orders for Coronavirus (COVID-19) PCR Test and Announces Distribution Agreements in Romania and Moldova

PreCheck Health Services, Inc. (OTC PINK: HLTY), a distributor of medical screening devices for use by physicians in managing a patient's health, announces it has ordered and paid for 37,500 of the Co-Diagnostics'...

HLTY : 0.5600 (+7.69%)
CODX : 9.15 (-2.66%)
Co-Diagnostics, Inc Completes Successful Clinical Evaluation Required for FDA Emergency Use Authorization

Co-Diagnostics, Inc. (Nasdaq:CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today that following a successful clinical evaluation...

CODX : 9.15 (-2.66%)
Has Co-Diagnostics (CODX) Outpaced Other Medical Stocks This Year?

Is (CODX) Outperforming Other Medical Stocks This Year?

CODX : 9.15 (-2.66%)
Co-Diagnostics JV CoSara First Indian Company to Receive License for COVID-19 Diagnostic

Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that CoSara Diagnostics...

CODX : 9.15 (-2.66%)
Recent Government Policies Aim to Stimulate the Market Recovery

The number of cities and governments around the world ordering people to distance themselves over the coronavirus (COVID-19) pandemic is rising; as of Tuesday, health officials have encouraged everyone...

CHFS : 0.4700 (+25.97%)
CODX : 9.15 (-2.66%)
OPK : 1.4000 (+1.45%)
NVAX : 13.05 (+2.43%)
OPGN : 2.94 (+6.52%)
Justin Anderson, CEO of PreCheck Health Services, Inc. is Featured in a New Interview at SmallCapVoice.com

SmallCapVoice.com Inc. and PreCheck Health Services, Inc. (OTC: HLTY) (the "Company"), a provider of medical screening devices which provide data to assist physicians in preventing and treating chronic...

HLTY : 0.5600 (+7.69%)
CODX : 9.15 (-2.66%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade CODX with:

Business Summary

Co-Diagnostics Inc. is a molecular diagnostics company. It develops, manufactures and markets a new, state-of-the-art diagnostics technology. The Company's technology is utilized for tests which are designed using the detection and/or analysis of nucleic acid molecules. It also uses proprietary technology...

See More

Key Turning Points

2nd Resistance Point 10.06
1st Resistance Point 9.61
Last Price 9.15
1st Support Level 8.79
2nd Support Level 8.42

See More

52-Week High 21.75
Fibonacci 61.8% 13.71
Fibonacci 50% 11.22
Last Price 9.15
Fibonacci 38.2% 8.74
52-Week Low 0.69

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar